Eli Lilly Locks In Retatrutide FDA Filing Date — Can the Stock Climb to $1,750 by 2027? Aug 7, 2026 Life Science
Down 46%, Yet Wall Street Predicts a 161% Surge: Would You Bet on This Weight-Loss Drug Stock? Aug 6, 2026 Life Science
Vertex Tops Q2 Estimates, But Investors Shift Focus to Crinetics Deal Integration Aug 4, 2026 Life Science
Weight-Loss Pipeline in Focus: Viking Therapeutics Could Be the Next Acquisition Target Jul 30, 2026 Life Science
Can Amgen’s Monthly Obesity Shot Rattle the Eli Lilly-Novo Nordisk Duopoly? Jul 29, 2026 Life Science
Gene-Editing Pioneer CRISPR Therapeutics Targets the $60 Billion CAR-T Market Jul 23, 2026 Life Science
Novo Nordisk Sues Eli Lilly Over ‘Deceptive’ GLP-1 Ads, Stock Impact Seen Limited Jul 21, 2026 Life Science
